Intracoronary epinephrine in the treatment of refractory no-reflow after primary percutaneous coronary intervention: a retrospective study

Aksu, Tolga; Guler, Tumer; ÇOLAK, AYŞE; Baysal, Erkan; Durukan, Mine; Sen, Taner; Guray, Umit

doi:10.1186/s12872-015-0004-6

Intracoronary epinephrine in the treatment of refractory no-reflow after primary percutaneous coronary intervention: a retrospective study

Aksu T., Guler T. E., ÇOLAK A., Baysal E., Durukan M., Sen T., ...Daha Fazla

BMC CARDIOVASCULAR DISORDERS, cilt.15, 2015 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 15
Basım Tarihi: 2015
Doi Numarası: 10.1186/s12872-015-0004-6
Dergi Adı: BMC CARDIOVASCULAR DISORDERS
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Anahtar Kelimeler: No-reflow, Epinephrine, Myocardial infarction
Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
Dokuz Eylül Üniversitesi Adresli: Hayır

Özet

Background: Despite the advances in medical and interventional treatment modalities, some patients develop epicardial coronary artery reperfusion but not myocardial reperfusion after primary percutaneous coronary intervention (PCI), known as no-reflow. The goal of this study was to evaluate the safety and efficacy of intracoronary epinephrine in reversing refractory no-reflow during primary PCI.